{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T10:50:20Z","timestamp":1792839020249,"version":"4.5.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP18K09302"],"award-info":[{"award-number":["JP18K09302"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In patients with epithelial ovarian cancer, whether metastasis to para-aortic lymph nodes located cephalad to the renal veins (supra-renal PAN) should be classified as regional lymph node metastasis or distant metastasis remains controversial. This study was a preliminary retrospective evaluation of the pattern of supra-renal PAN metastasis in patients with epithelial ovarian cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The subjects were 25 patients with epithelial ovarian cancer, primary peritoneal cancer, or fallopian tube cancer who underwent systematic dissection of the para-aortic nodes, including the supra-renal PAN, and pelvic lymph nodes (PLN). Patient factors, perioperative factors, the number of dissected lymph nodes, and pathological lymph node metastasis were investigated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Supra-renal PAN metastasis was found in 4\/25 patients (16.0%). None of the 14 patients with pT1 or pT2 disease had supra-renal PAN metastasis, while 4\/11 patients (36.4%) with pT3 or ypT3 disease had such metastases. None of the patients had isolated supra-renal PAN metastasis, while patients with supra-renal PAN metastasis also had multiple metastases to the infra-renal PAN and PLN.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In patients with epithelial ovarian cancer, supra-renal PAN metastases might be considered to be distant rather than regional metastases. Further studies are needed to better define the clinical significance of supra-renal PAN metastasis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12957-020-01841-8","type":"journal-article","created":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T22:02:30Z","timestamp":1585778550000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Metastasis to para-aortic lymph nodes cephalad to the renal veins in patients with ovarian cancer"],"prefix":"10.1186","volume":"18","author":[{"given":"Shinichi","family":"Komiyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Rikitake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mineto","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,1]]},"reference":[{"key":"1841_CR1","doi-asserted-by":"crossref","unstructured":"Committee on Classification of Regional Lymph Nodes of the Japan Society of Clinical Oncology. Classification of regional lymph nodes in Japan. Int J Clin Oncol 2003;8:248-275.","DOI":"10.1007\/s10147-003-0343-7"},{"key":"1841_CR2","doi-asserted-by":"crossref","unstructured":"Prat J ; FIGO Committee on Gynecologic Oncology. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet 2014;124:1-5.","DOI":"10.1016\/j.ijgo.2013.10.001"},{"key":"1841_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ygyno.2017.02.015","volume":"145","author":"S Komiyama","year":"2017","unstructured":"Komiyama S, Manrai M, Takahashi R, et al. Safe dissection of high paraaortic lymph nodes superior to the renal vein in ovarian, primary peritoneal, or fallopian tube cancer by the \u201cKomiyama\u2019s maneuver\u201d, a modification of Kocher\u2019s maneuver. Gynecol Oncol. 2017;145:407\u20138.","journal-title":"Gynecol Oncol"},{"key":"1841_CR4","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) Version 4.03. [Cited 11 Jul 2018.] Available at: https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm#ctc_40."},{"key":"1841_CR5","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.ygyno.2011.09.013","volume":"123","author":"M Kleppe","year":"2011","unstructured":"Kleppe M, Wang T, Van Gorp T, et al. Lymph node metastasis in stages I and II ovarian cancer: a review. Gynecol Oncol. 2011;123:610\u20134.","journal-title":"Gynecol Oncol"},{"key":"1841_CR6","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1200\/JCO.2009.25.3617","volume":"28","author":"A du Bois","year":"2010","unstructured":"du Bois A, Reuss A, Harter P, et al. Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom; Groupe d\u2019Investigateurs Nationaux pour l\u2019Etude des Cancers Ovariens. Potential role of lymphadenectomy in advanced ovarian cancer: a combined exploratory analysis of three prospectively randomized phase III multicenter trials. J Clin Oncol. 2010;28:1733\u20139.","journal-title":"J Clin Oncol"},{"key":"1841_CR7","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1111\/j.1525-1438.2007.00931.x","volume":"17","author":"P Harter","year":"2007","unstructured":"Harter P, Gnauert K, Hils R, et al. Pattern and clinical predictors of lymph node metastases in epithelial ovarian cancer. Int J Gynecol Cancer. 2007;17:1238\u201344.","journal-title":"Int J Gynecol Cancer"},{"key":"1841_CR8","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1245\/s10434-015-4959-4","volume":"23","author":"K Gasimli","year":"2016","unstructured":"Gasimli K, Braicu EI, Nassir M, et al. Lymph node involvement pattern and survival differences of FIGO IIIC and FIGO IIIA1 ovarian cancer patients after primary complete tumor debulking surgery: a 10-year retrospective analysis of the Tumor Bank Ovarian Cancer Network. Ann Surg Oncol. 2016;23:1279\u201386.","journal-title":"Ann Surg Oncol"},{"key":"1841_CR9","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2018.29.e12","volume":"29","author":"A Ayhan","year":"2018","unstructured":"Ayhan A, Ozkan NT, Sar\u0131 ME, et al. Impact of lymph node ratio on survival in stage III ovarian high-grade serous cancer: a Turkish Gynecologic Oncology Group study. J Gynecol Oncol. 2018;29:e12.","journal-title":"J Gynecol Oncol"},{"key":"1841_CR10","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1111\/IGC.0b013e3181b8a07c","volume":"19","author":"M Fournier","year":"2009","unstructured":"Fournier M, Stoeckle E, Guyon F, et al. Lymph node involvement in epithelial ovarian cancer: sites and risk factors in a series of 355 patients. Int J Gynecol Cancer. 2009;19:1307\u201313.","journal-title":"Int J Gynecol Cancer"},{"key":"1841_CR11","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1245\/s10434-012-2400-9","volume":"19","author":"A Fagotti","year":"2012","unstructured":"Fagotti A, De Iaco P, Fanfani F, et al. Systematic pelvic and aortic lymphadenectomy in advanced ovarian cancer patients at the time of interval debulking surgery: a double-institution case-control study. Ann Surg Oncol. 2012;19:3522\u20137.","journal-title":"Ann Surg Oncol"},{"key":"1841_CR12","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/jso.24669","volume":"116","author":"KJ Eoh","year":"2017","unstructured":"Eoh KJ, Yoon JW, Lee I, et al. The efficacy of systematic lymph node dissection in advanced epithelial ovarian cancer during interval debulking surgery performed after neoadjuvant chemotherapy. J Surg Oncol. 2017;116:329\u201336.","journal-title":"J Surg Oncol"},{"key":"1841_CR13","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/jnci\/dji102","volume":"97","author":"PB Panici","year":"2005","unstructured":"Panici PB, Maggioni A, Hacker N, et al. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Natl Cancer Inst. 2005;97:560\u20136.","journal-title":"J Natl Cancer Inst"},{"key":"1841_CR14","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1056\/NEJMoa1808424","volume":"380","author":"P Harter","year":"2019","unstructured":"Harter P, Sehouli J, Lorusso D, et al. A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms. N Engl J Med. 2019;380:822\u201332.","journal-title":"N Engl J Med"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-020-01841-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12957-020-01841-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-020-01841-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T23:13:42Z","timestamp":1617232422000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-020-01841-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,1]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1841"],"URL":"https:\/\/doi.org\/10.1186\/s12957-020-01841-8","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,1]]},"assertion":[{"value":"3 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in compliance with the Declaration of Helsinki, and the protocol was approved by the ethical committee of Toho University Ohashi Medical Center (approval number H-17044). Informed consent was waived by the board due to the retrospective design of this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SK has received speaker\u2019s honoraria from Chugai Pharmaceutical. The other authors declare that they have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"64"}}